Mattison LK - Search Results

1

(13)C-5-FU breath test current status and future directions: a comprehensive review.

Ezzeldin HH, Acosta EP, Mattison LK, Fourie J, Modak A, Diasio RB. Ezzeldin HH, et al. Among authors: mattison lk. J Breath Res. 2009 Dec;3(4):047002. doi: 10.1088/1752-7155/3/4/047002. Epub 2009 Nov 27. J Breath Res. 2009. PMID: 21386199

2

Rapid identification of dihydropyrimidine dehydrogenase deficiency by using a novel 2-13C-uracil breath test.

Mattison LK, Ezzeldin H, Carpenter M, Modak A, Johnson MR, Diasio RB. Mattison LK, et al. Clin Cancer Res. 2004 Apr 15;10(8):2652-8. doi: 10.1158/1078-0432.ccr-03-0374. Clin Cancer Res. 2004. PMID: 15102667

3

Increased prevalence of dihydropyrimidine dehydrogenase deficiency in African-Americans compared with Caucasians.

Mattison LK, Fourie J, Desmond RA, Modak A, Saif MW, Diasio RB. Mattison LK, et al. Clin Cancer Res. 2006 Sep 15;12(18):5491-5. doi: 10.1158/1078-0432.CCR-06-0747. Clin Cancer Res. 2006. PMID: 17000684

4

Methylation of the DPYD promoter: an alternative mechanism for dihydropyrimidine dehydrogenase deficiency in cancer patients.

Ezzeldin HH, Lee AM, Mattison LK, Diasio RB. Ezzeldin HH, et al. Among authors: mattison lk. Clin Cancer Res. 2005 Dec 15;11(24 Pt 1):8699-705. doi: 10.1158/1078-0432.CCR-05-1520. Clin Cancer Res. 2005. PMID: 16361556

5

The uracil breath test in the assessment of dihydropyrimidine dehydrogenase activity: pharmacokinetic relationship between expired 13CO2 and plasma [2-13C]dihydrouracil.

Mattison LK, Fourie J, Hirao Y, Koga T, Desmond RA, King JR, Shimizu T, Diasio RB. Mattison LK, et al. Clin Cancer Res. 2006 Jan 15;12(2):549-55. doi: 10.1158/1078-0432.CCR-05-2020. Clin Cancer Res. 2006. PMID: 16428499

6

Genetic regulation of beta-ureidopropionase and its possible implication in altered uracil catabolism.

Thomas HR, Ezzeldin HH, Guarcello V, Mattison LK, Fridley BL, Diasio RB. Thomas HR, et al. Among authors: mattison lk. Pharmacogenet Genomics. 2008 Jan;18(1):25-35. doi: 10.1097/FPC.0b013e3282f2f134. Pharmacogenet Genomics. 2008. PMID: 18216719

7

Genetic regulation of dihydropyrimidinase and its possible implication in altered uracil catabolism.

Thomas HR, Ezzeldin HH, Guarcello V, Mattison LK, Fridley BL, Diasio RB. Thomas HR, et al. Among authors: mattison lk. Pharmacogenet Genomics. 2007 Nov;17(11):973-87. doi: 10.1097/FPC.0b013e3282f01788. Pharmacogenet Genomics. 2007. PMID: 18075467

8

A DPYD variant (Y186C) in individuals of african ancestry is associated with reduced DPD enzyme activity.

Offer SM, Lee AM, Mattison LK, Fossum C, Wegner NJ, Diasio RB. Offer SM, et al. Among authors: mattison lk. Clin Pharmacol Ther. 2013 Jul;94(1):158-66. doi: 10.1038/clpt.2013.69. Epub 2013 Apr 3. Clin Pharmacol Ther. 2013. PMID: 23588312 Free PMC article.

9

Implications of dihydropyrimidine dehydrogenase on 5-fluorouracil pharmacogenetics and pharmacogenomics.

Mattison LK, Soong R, Diasio RB. Mattison LK, et al. Pharmacogenomics. 2002 Jul;3(4):485-92. doi: 10.1517/14622416.3.4.485. Pharmacogenomics. 2002. PMID: 12164772 Review.

10

A comparative analysis of translated dihydropyrimidine dehydrogenase cDNA; conservation of functional domains and relevance to genetic polymorphisms.

Mattison LK, Johnson MR, Diasio RB. Mattison LK, et al. Pharmacogenetics. 2002 Mar;12(2):133-44. doi: 10.1097/00008571-200203000-00007. Pharmacogenetics. 2002. PMID: 11875367

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13 results

Search Page

Filters